相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The PRISMA 2020 statement: An updated guideline for reporting systematic reviews
Matthew J. Page et al.
INTERNATIONAL JOURNAL OF SURGERY (2021)
Caveolin-1 Expression Together with VEGF can be a Predictor for Lung Metastasis and Poor Prognosis in Osteosarcoma
Fatma El-Zahraa Ammar Mohamed et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Epidemiology and Risk Factors of Osteosarcoma
Leissan R. Sadykova et al.
CANCER INVESTIGATION (2020)
Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma
Hongzeng Wu et al.
JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH (2019)
PD-1 inhibition in sarcoma still needs investigation reply
Hussein A. Tawbi et al.
LANCET ONCOLOGY (2018)
VEGF may contribute to macrophage recruitment and M2 polarization in the decidua
Karen C. Wheeler et al.
PLOS ONE (2018)
A Meta-Analysis of Vascular Endothelial Growth Factor for Nasopharyngeal Cancer Prognosis
Feng Wang et al.
FRONTIERS IN ONCOLOGY (2018)
The pharmacogenomics of osteosarcoma
M. Serra et al.
PHARMACOGENOMICS JOURNAL (2017)
High expression levels of Cyr61 and VEGF are associated with poor prognosis in osteosarcoma
Yanming Liu et al.
PATHOLOGY RESEARCH AND PRACTICE (2017)
Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma
Gang Han et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2016)
Prognostic significance of VEGF-C immunohistochemical expression in colorectal cancer: A meta-analysis
Shaoqi Zong et al.
CLINICA CHIMICA ACTA (2016)
Ten years of anti-vascular endothelial growth factor therapy
Napoleone Ferrara et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Clinical significance of hypoxia-inducible factor 1 and VEGF-A in osteosarcoma
Huanli Zhao et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2015)
VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors
Thibault Voron et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Expression profile of Twist, vascular endothelial growth factor and CD34 in patients with different phases of osteosarcoma
Pengfei Lei et al.
ONCOLOGY LETTERS (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
CORRELATION BETWEEN THE EXPRESSION OF VEGF AND SURVIVAL IN OSTEOSARCOMA
Andre Mathias Baptista et al.
ACTA ORTOPEDICA BRASILEIRA (2014)
Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis
Xiao-Wei Yu et al.
TUMOR BIOLOGY (2014)
Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis
Yanfeng Zhuang et al.
TUMOR BIOLOGY (2014)
Molecular mechanisms of chemoresistance in osteosarcoma
Hongtao He et al.
ONCOLOGY LETTERS (2014)
Conversion of Peripheral Blood NK Cells to a Decidual NK-like Phenotype by a Cocktail of Defined Factors
Ana Sofia Cerdeira et al.
JOURNAL OF IMMUNOLOGY (2013)
The Proangiogenic Phenotype of Natural Killer Cells in Patients with Non-Small Cell Lung Cancer
Antonino Bruno et al.
NEOPLASIA (2013)
Vascular Permeability and Drug Delivery in Cancers
Sandy Azzi et al.
FRONTIERS IN ONCOLOGY (2013)
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2
N. G. Gavalas et al.
BRITISH JOURNAL OF CANCER (2012)
Expression of Vascular Endothelial Growth Factor correlates with the advance of clinical osteosarcoma
John Lammli et al.
INTERNATIONAL ORTHOPAEDICS (2012)
Predicting chemosensitivity in osteosarcoma prior to chemotherapy: An investigational study of biomarkers with immunohistochemistry
Yong Chen et al.
ONCOLOGY LETTERS (2012)
Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma
Feng Lin et al.
MEDICAL ONCOLOGY (2011)
A Prognostic Evaluation of Vascular Endothelial Growth Factor in Children and Young Adults With Osteosarcoma
Iwona Lugowska et al.
PEDIATRIC BLOOD & CANCER (2011)
VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma
Quan Zhou et al.
SURGICAL ONCOLOGY-OXFORD (2011)
Correlation Between Clinical Outcome and Growth Factor Pathway Expression in Osteogenic Sarcoma
Ayesha Abdeen et al.
CANCER (2009)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
Hypoxia markers in human osteosarcoma:: An exploratory study
Hiroo Mizobuchi et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2008)
Prognostic Significance of alpha(V) Integrin and VEGF in Osteosarcoma after Chemotherapy
Yunpeng Huang et al.
ONKOLOGIE (2008)
Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas
Hye-Rim Park et al.
PATHOLOGY RESEARCH AND PRACTICE (2008)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Vascular endothelial growth factor expression in osteosarcoma
R. M. Charity et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2006)
CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis
Y Oda et al.
MODERN PATHOLOGY (2006)
Expression and significance of TGF-β isoform and VEGF in osteosarcoma
ST Jung et al.
ORTHOPEDICS (2005)
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis
S Weis et al.
JOURNAL OF CELL BIOLOGY (2004)
Tumorigenesis and the angiogenic switch
G Bergers et al.
NATURE REVIEWS CANCER (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
分享论文
